He aha ʻo Pegvisomant: Nā hoʻohana, ka nui, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau kūikawā ʻo Pegvisomant e ālai ana i ka hana ʻana o ka hormone ulu i loko o kou kino. Ua hoʻolālā kūikawā ʻia ia e mālama i ka acromegaly, kahi maʻi laha ʻole kahi e hana ai kou kino i ka nui o ka hormone ulu, e alakaʻi ana i nā lima, nā wāwae, a me nā hiʻohiʻona maka.

Hana ʻokoʻa kēia lāʻau lapaʻau mai ka hapa nui o nā lāʻau lapaʻau acromegaly. Ma kahi o ka hoʻemi ʻana i ka hana ʻana o ka hormone ulu, pale ia i ka hormone mai ka hana ʻana ma ke kelepona, e hāʻawi ana i ka manaʻolana no ka poʻe i loaʻa ʻole ke kōkua me nā lāʻau lapaʻau ʻē aʻe.

He aha ʻo Pegvisomant?

ʻO Pegvisomant kahi mea kūʻē i ka mea hoʻokipa hormone ulu āu e hoʻokomo ai ma lalo o kou ʻili i kēlā me kēia lā. E noʻonoʻo iā ia he kī e komo i loko o ka laka like me ka hormone ulu akā ʻaʻole ia e huli, e ālai pono ana i ka hormone ulu mai ka hana ʻana i kāna hana i loko o kou kino.

Hana ʻia kēia lāʻau lapaʻau ma o ka biotechnology kiʻekiʻe, e lilo ia i lāʻau lapaʻau paʻakikī akā i manaʻo nui ʻia. Manaʻo ʻia ʻo ia kekahi o nā koho maikaʻi loa no ka mālama ʻana i nā hōʻailona acromegaly i ka wā i hana ʻole ai nā lāʻau lapaʻau ʻē aʻe.

Hele mai ka lāʻau lapaʻau ma ke ʻano he pauka āu e hui pū ai me ka wai sterile ma mua o ka hoʻokomo ʻana. E aʻo kāu hui mālama ola iā ʻoe pehea e hoʻomākaukau ai a hoʻokomo palekana i ka home.

No ke aha e hoʻohana ʻia ai ʻo Pegvisomant?

Hoʻomaʻamaʻa ʻo Pegvisomant i ka acromegaly i nā mākua i ka wā i mālama ʻole ai ke ʻoki a me nā lāʻau lapaʻau ʻē aʻe i ke kūlana. Hiki mai ka Acromegaly i ka wā e hana ai kahi maʻi maʻi i loko o kou ʻōpū pituitary i ka nui o ka hormone ulu, e hana ana i nā ʻāpana o kou kino e ulu ʻokoʻa.

Hiki i kāu kauka ke ʻōlelo iā pegvisomant inā ua hoʻāʻo ʻoe i nā analog somatostatin e like me octreotide a i ʻole lanreotide, akā e mau ana kāu pae IGF-1. ʻO ka IGF-1 kahi protein e hōʻike ana i ka nui o ka hormone ulu e hana maoli ana i loko o kou kino.

He mea kōkua nui ka lāʻau lapaʻau no ka poʻe i loaʻa nā hopena ʻaoʻao nui mai nā lāʻau lapaʻau acromegaly ʻē aʻe a i ʻole ka poʻe i pane ʻole nā ʻōpū i nā lāʻau lapaʻau maʻamau. Hiki nō ke hoʻohana pū ʻia me nā lāʻau lapaʻau ʻē aʻe no ka mālama maikaʻi ʻana.

Pehea e hana ai ʻo Pegvisomant?

Hana ʻo Pegvisomant ma ka pale ʻana i nā mea hoʻokipa hormone ulu ma kou kino a pau, e pale ana i ka hormone ulu mai ka hoʻopaʻa ʻana i nā cell a me ka hoʻoulu ʻana i kāna mau hopena. He ʻokoʻa kēia mai nā lāʻau lapaʻau acromegaly ʻē aʻe e hoʻāʻo nei e hōʻemi i ka hana hormone ulu mai ke kumu.

Ke hiki ʻole i ka hormone ulu ke hoʻopili i kāna mau mea hoʻokipa, e hooki kou ate i ka hana ʻana i ka IGF-1 nui, nona ke kuleana no ka hapa nui o nā hōʻailona acromegaly. He mea maikaʻi loa kēia hana no ka mea e hana ana ia me ka nānā ʻole i ka nui o ka hormone ulu e hana ai kou ʻōpū.

Ua manaʻo ʻia he ikaika a maikaʻi loa ka lāʻau lapaʻau no ka mālama ʻana i ka acromegaly. ʻIke ka hapa nui o nā kānaka i nā hoʻomaikaʻi nui ʻana i kā lākou pae IGF-1 i loko o kekahi mau mahina o ka hoʻomaka ʻana i ka lāʻau lapaʻau, akā hiki ke ʻokoʻa nā pane pilikino.

Pehea e lawe ai au i ka Pegvisomant?

E hoʻokomo ʻoe i ka pegvisomant ma lalo o kou ʻili i hoʻokahi manawa i ka lā, maʻamau i kou ʻūhā, ʻōpū, a i ʻole ka lima luna. E hoʻomaka kāu kauka iā ʻoe ma kahi mahele hoʻouka, a laila e hoʻoponopono i kāu mahele i kēlā me kēia lā ma muli o kāu pae IGF-1 a me ka maikaʻi o kou pane ʻana i ka lāʻau lapaʻau.

Ma mua o ka hoʻokomo ʻana, pono ʻoe e hui i ka pauka me ka wai sterile i hāʻawi ʻia. E waiho i ka hui no kekahi mau minuke me ka lulu ʻole ʻana, no ka mea, hiki i ka lulu ʻana ke hōʻino i ka lāʻau lapaʻau. Pono e maopopo a me ka ʻole o ke kala ka hopena ke hui pono ʻia.

Hiki iā ʻoe ke lawe i ka pegvisomant me ka ʻole o ka meaʻai, no ka mea, ʻaʻole pili ka ʻai ʻana i ke ʻano o ka hana ʻana o ka lāʻau lapaʻau. Eia naʻe, e hoʻāʻo e hoʻokomo iā ia i ka manawa like i kēlā me kēia lā e mālama i nā pae paʻa i kou kino.

E hoʻololi i kāu mau wahi hoʻokomo e pale ai i ka huhū o ka ʻili a i ʻole ka hana ʻana o nā puʻupuʻu. E mālama i kahi āu e hoʻokomo ai i kēlā me kēia lā, a mai hoʻohana i ka wahi like no kekahi mau lā i ka lālani.

Pehea ka lōʻihi e lawe ai au i ka Pegvisomant?

Pono ka hapa nui o nā kānaka me ka acromegaly e lawe i ka pegvisomant no ka wā lōʻihi e mālama ai i ko lākou maʻi. He lapaʻau maʻamau kēia no ke ola a pau, no ka mea, he maʻi maʻi ka acromegaly e pono ai ka mālama mau.

E nānā mau kāu kauka i kāu mau pae IGF-1, maʻamau i kēlā me kēia 4-6 pule i ka wā mua, a laila ʻaʻole pinepine ke paʻa nā pae. E hoʻoponopono lākou i kāu mahele ma muli o kēia mau hopena a me ke ʻano o kou manaʻo.

Hiki i kekahi poʻe ke hōʻemi i kā lākou mahele i ka manawa a i ʻole e hoʻomaha mai ka lapaʻau ʻana, akā pili kēia i kou kūlana pilikino a me nā ʻano o ka maʻi. Mai hooki i ka lawe ʻana i ka pegvisomant me ka ʻole e kūkākūkā mua me kāu hui mālama ola.

He aha nā hopena ʻaoʻao o Pegvisomant?

E like me nā lāʻau lapaʻau a pau, hiki i ka pegvisomant ke hana i nā hopena ʻaoʻao, ʻoiai he nui ka poʻe e ʻae maikaʻi iā ia. ʻO nā hopena ʻaoʻao maʻamau he maʻalahi a hiki ke mālama ʻia me ka nānā pono a me ka mālama.

Eia nā hopena ʻaoʻao āu e ʻike ai, e hoʻomaka ana me nā mea maʻamau:

• Nā hopena ma ka pūnaewele injection e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻeha maʻalahi
• Nā hōʻailona e like me ka maʻi flu me ka luhi, nā ʻeha ʻiʻo, a i ʻole ke kuni maʻalahi
• Nā poʻo, e hoʻomaikaʻi pinepine i ka wā e hoʻoponopono ai kou kino
• Nausea a i ʻole ka ʻoluʻolu o ka ʻōpū
• ʻO ka ʻūlū a i ʻole ka māmā
• Nā loli i nā hoʻokolohua hana ate

ʻO nā hopena ʻaoʻao koʻikoʻi akā ʻaʻole maʻamau e hiki ke komo i nā pilikia ate nui, ʻo ia ke kumu e nānā mau ai kāu kauka i kāu hana ate. ʻIke kekahi poʻe i ka ulu ʻana o ka maʻi, ʻoiai he kakaikahi kēia.

Hoʻomaikaʻi ka hapa nui o nā hopena ma ka pūnaewele injection me ka ʻenehana kūpono a me ka hoʻololi ʻana i ka pūnaewele. Inā loaʻa iā ʻoe ka ʻulaʻula mau, ka pehu, a i ʻole ka ʻeha ma nā pūnaewele injection, e hōʻike i kāu hui mālama ola i hiki iā lākou ke kōkua iā ʻoe e hoʻoponopono.

ʻO wai ka mea ʻaʻole pono e lawe i ka Pegvisomant?

ʻAʻole kūpono ʻo Pegvisomant no nā mea a pau i loaʻa i ka acromegaly. ʻAʻole pono ʻoe e lawe i kēia lāʻau lapaʻau inā he maʻi ʻoe i ka pegvisomant a i ʻole kekahi o kāna mau mea, a i ʻole inā he maʻi ate koʻikoʻi kou.

Pono kāu kauka e loiloi pono i kou kūlana inā he pilikia ate kou, ka maʻi diabetes, a i ʻole nā maʻi puʻuwai. Hiki i ka Pegvisomant ke hoʻopilikia i nā pae kōpaʻa koko a pono paha e hoʻoponopono i nā lāʻau lapaʻau diabetes.

Pono nā wāhine hāpai a i ʻole e hānai ana i ka waiū e kūkākūkā i nā pilikia a me nā pōmaikaʻi me kā lākou hui mālama ola, no ka mea, he palena ka ʻike e pili ana i ka palekana o ka pegvisomant i ka wā hāpai. Hiki i kāu kauka ke ʻōlelo aku i nā lāʻau lapaʻau ʻē aʻe i kēia mau manawa.

Pono paha ka poʻe me kekahi mau ʻano o nā maʻi maʻi pituitary i ka nānā ʻana, no ka mea, hiki i ka pegvisomant ke ʻae i kekahi mau maʻi maʻi e ulu. ʻAʻole pinepine kēia, akā he mea ia e nānā ai kāu hui mālama ola.

Nā inoa inoa Pegvisomant

Loaʻa ʻo Pegvisomant ma lalo o ka inoa inoa ʻo Somavert ma ka hapa nui o nā ʻāina. ʻO kēia ka inoa inoa mua āu e hālāwai ai i ka wā e loaʻa ai kāu kauoha a i ʻole ke kūkākūkā ʻana i ka lāʻau lapaʻau me kāu hui mālama ola.

Hana ʻia ka lāʻau lapaʻau e Pfizer a loaʻa ma nā ʻāina he nui a puni ka honua. Hiki i kāu hale kūʻai lāʻau lapaʻau ke kuhikuhi iā ia ma kona inoa generic, pegvisomant, ʻoiai ʻo ka inoa inoa ʻo Somavert i hoʻohana pinepine ʻia.

Ke kamaʻilio ʻana me kāu hui mālama ola a i ʻole ka hui ʻinikua, hiki iā ʻoe ke hoʻohana i kekahi inoa, akā ʻo Somavert ka mea maʻamau e ʻike ʻia ma nā ʻōmole kauoha a me nā palapala ʻinikua.

Nā koho ʻē aʻe o Pegvisomant

Inā ʻaʻole kūpono ka pegvisomant iā ʻoe, aia kekahi mau lāʻau lapaʻau acromegaly ʻē aʻe. Hoʻāʻo pinepine ʻia nā analog somatostatin e like me octreotide a me lanreotide i ka mua, no ka mea, hiki ke hāʻawi ʻia ma ke ʻano he injections mahina a hana maikaʻi no ka nui o nā kānaka.

ʻO Cabergoline, he dopamine agonist, he koho ʻē aʻe i hele mai i ke ʻano o ka pila. He mea kōkua nui ia no ka poʻe nona nā maʻi e hana ana i ka hormone ulu a me ka prolactin, ʻoiai ʻaʻole ia he mea maikaʻi e like me nā lāʻau lapaʻau ʻē aʻe.

No kekahi poʻe, ʻo ka wehe ʻana i ka maʻi pituitary ma ke ʻoki ʻana ke koho maikaʻi loa, ʻoiai inā he liʻiliʻi ka maʻi a maʻalahi ke komo. Hiki nō ke noʻonoʻo ʻia ka lāʻau lapaʻau radiation i kekahi mau kūlana.

E hana pū kāu kauka me ʻoe e ʻimi i ke ala lapaʻau maikaʻi loa e pili ana i nā ʻano o kāu maʻi, ka paʻakikī o nā hōʻailona, a me nā makemake pilikino. I kekahi manawa, ʻoi aku ka maikaʻi o ka hui ʻana i nā lāʻau lapaʻau ma mua o ka hoʻohana ʻana i hoʻokahi wale nō.

ʻOi aku ka maikaʻi o Pegvisomant ma mua o Octreotide?

Hana ʻokoʻa ʻo Pegvisomant a me octreotide a loaʻa i kēlā me kēia me nā pono like ʻole. ʻOi aku ka maikaʻi o Pegvisomant i ka hoʻomaʻamaʻa ʻana i nā pae IGF-1, ʻoiai no ka poʻe i pane ʻole i ka octreotide a i ʻole nā lāʻau lapaʻau like.

Loaʻa i ka Octreotide ka pono o ka hoʻemi ʻana i nā maʻi pituitary, ʻaʻole hana ʻo pegvisomant. Hele mai nō hoʻi ʻo Octreotide ma ke ʻano he injection mahina, a he nui ka poʻe i ʻike he mea maʻalahi ma mua o nā injection pegvisomant i kēlā me kēia lā.

Eia naʻe, ʻo ka pegvisomant ke kumu pinepine i nā hopena ʻaoʻao digestive liʻiliʻi ma mua o ka octreotide, kahi e hana pinepine ai i ka nausea, diarrhea, a me nā pilikia gallbladder. ʻO kēia ka mea e ʻae ʻia ai ka pegvisomant no ka poʻe i ʻike i nā pilikia gastrointestinal.

Hiki i kāu kauka ke hoʻomaka me ka octreotide mua, a laila e hoʻololi i ka pegvisomant inā ʻaʻole e maʻamau kāu pae IGF-1. Pono kekahi poʻe i ka hoʻohana ʻana i nā lāʻau lapaʻau ʻelua i ka manawa like no ka mana maikaʻi.

Nā nīnau i nīnau pinepine ʻia e pili ana iā Pegvisomant

Q1. Palekana ʻo Pegvisomant no ka poʻe me ka maʻi diabetes?

Hiki ke hoʻohana ʻia ʻo Pegvisomant i ka poʻe me ka maʻi diabetes, akā pono e nānā pono. Hiki i ka lāʻau lapaʻau ke hoʻopilikia i nā pae kō koko, i kekahi manawa e maʻalahi ai ka mālama ʻana i ka wā e hoʻomaikaʻi ai kāu acromegaly.

E makemake paha kāu kauka e nānā pono i kou kōpaʻa koko ke hoʻomaka ʻoe i ka pegvisomant, ʻoi loa i nā mahina mua. Pono paha ʻoe e hoʻoponopono i kāu mau lāʻau lapaʻau maʻi maʻi ma muli o ka loli ʻana o kou pae hormone ulu.

He nui nā kānaka me ka acromegaly a me ka maʻi maʻi e ʻike maoli nei e hoʻomaikaʻi ana kā lākou kaohi kōpaʻa koko me ka mālama ʻana i ka pegvisomant, no ka mea, hiki i ka nui o ka hormone ulu ke paʻakikī i ka mālama ʻana i ka maʻi maʻi. Eia naʻe, ʻokoʻa nā pane pilikino, no laila he mea nui ka nānā pono ʻana.

Q2. He aha kaʻu e hana ai inā hoʻohana hewa wau i ka nui o ka Pegvisomant?

Inā ʻoe e hoʻokomo hewa i ka nui o ka pegvisomant, e hoʻokaʻaʻike koke i kāu mea mālama ola a i ʻole ke kikowaena mana ʻawa. Mai kali e ʻike inā e hoʻomohala ʻoe i nā hōʻailona, ​​no ka mea, he mea nui ka loaʻa ʻana o ke alakaʻi wikiwiki.

Hiki i ka overdose ke hoʻohaʻahaʻa loa i kāu pae IGF-1, e alakaʻi ana i nā hōʻailona e like me ka nāwaliwali, ka luhi, a i ʻole nā ​​loli i ke kōpaʻa koko. Makemake paha kāu kauka e nānā pono iā ʻoe a i ʻole e hoʻoponopono i kāu mau lāʻau e hiki mai ana.

No ka pale ʻana i nā overdoses e hiki mai ana, e nānā mau i kāu lāʻau ma mua o ka hui ʻana a me ka hoʻokomo ʻana. Inā ʻaʻole ʻoe maopopo i ka nui kūpono, e kelepona i kāu hui mālama ola ma mua o ke koho ʻana.

Q3. He aha kaʻu e hana ai inā e poina iaʻu kahi lāʻau o Pegvisomant?

Inā poina iā ʻoe kahi lāʻau o ka pegvisomant, e lawe koke iā ia ke hoʻomanaʻo ʻoe, ke ʻole kokoke ka manawa no kāu lāʻau i hoʻonohonoho ʻia. I kēlā hihia, e lele i ka lāʻau i poina a hoʻomau me kāu papa manawa maʻamau.

Mai lawe i ʻelua lāʻau i ka manawa hoʻokahi e hoʻopiha ai i kahi lāʻau i poina, no ka mea, hiki i kēia ke hoʻohaʻahaʻa loa i kāu pae IGF-1. ʻAʻole e hoʻopilikia nui kahi lāʻau i poina i kāu mana acromegaly.

Inā poina pinepine ʻoe i nā lāʻau, e noʻonoʻo e hoʻonohonoho i kahi alarm i kēlā me kēia lā a i ʻole e hoʻohana i kahi polokalamu hoʻomanaʻo pill. ʻO ka hoʻopaʻa ʻana i kēlā me kēia lā e kōkua i ka mālama ʻana i ka mana paʻa o kāu pae IGF-1.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana i ka Pegvisomant?

ʻAʻole pono ʻoe e hooki i ka lawe ʻana i ka pegvisomant me ke kūkākūkā ʻole ʻana me kāu hui mālama ola mua. Pono ka hapa nui o nā kānaka me ka acromegaly i ka lāʻau lapaʻau no ke ola a pau e mālama i ko lākou maʻi.

Hiki i kāu kauka ke noʻonoʻo e hōʻemi i kāu mahele lāʻau a i ʻole e hooki i ka lāʻau lapaʻau inā e emi nui ana kāu maʻi maʻi pituitary a i ʻole inā e loaʻa iā ʻoe nā hopena ʻaoʻao koʻikoʻi. Eia naʻe, pono kēia hoʻoholo i ka loiloi pono ʻana i kou kūlana pilikino.

Inā ʻoe e noʻonoʻo ana e hooki i ka pegvisomant ma muli o nā hopena ʻaoʻao a i ʻole nā hopohopo ʻē aʻe, e kamaʻilio ākea me kāu hui mālama ola. Hiki iā lākou ke hoʻoponopono i kāu hoʻolālā lapaʻau a i ʻole e hoʻoponopono i kāu mau hopohopo me ka hooki ʻole ʻana i ka lāʻau lapaʻau.

Q5. Hiki iaʻu ke hele i ka wā e lawe ana i ka Pegvisomant?

ʻAe, hiki iā ʻoe ke hele i ka wā e lawe ana i ka pegvisomant, akā pono ia i kekahi hoʻolālā. Pono ʻoe e hoʻopili i ka lāʻau lapaʻau lawa no kāu huakaʻi holoʻokoʻa me kekahi mau lā hou, a e mālama i loko o ka pahu hau inā hiki.

I ka lele ʻana, e lawe i kāu pegvisomant i loko o kāu ʻeke lawe me kahi leka mai kāu kauka e wehewehe ana i ke kumu e pono ai ʻoe e hele me nā syringes a me ka lāʻau lapaʻau. Ua kamaʻāina ka palekana o ke kahua mokulele i nā pono olakino, akā kōkua ka palapala i ka pale ʻana i nā lohi.

E noʻonoʻo pehea ʻoe e mālama ai i nā loli o ka manawa inā ʻoe e hele ana i ka honua. Hiki i kāu kauka ke kōkua iā ʻoe e hoʻolālā i kahi papa hana dosing e hana ana me kāu huakaʻi huakaʻi me ka mālama ʻana i ka lāʻau lapaʻau mau.